doxazosin mesylate
PolandDrugs containing this active substance
-
The medicine is used to treat arterial hypertension and to relieve the symptoms of an enlarged prostate.
Form: tablets
Active substance Dosage doxazosin mesylate 2.42 mg ATC: C02CA04
Manufacturer: Adamed Pharma S.A. APL Swift Services (Malta) Ltd.
-
The medicine is used to treat arterial hypertension and to relieve the symptoms of an enlarged prostate.
Form: tablets
Active substance Dosage doxazosin mesylate 4.84 mg ATC: C02CA04
Manufacturer: Adamed Pharma S.A. APL Swift Services (Malta) Ltd.
-
It is used in the treatment of essential hypertension and in the relief of clinical symptoms of benign prostatic hyperplasia.
Form: tablets
Active substance Dosage doxazosin mesylate 1.22 mg ATC: C02CA04
Manufacturer: Generics Farmaceutica, S.A.
-
The medicine is used to treat essential hypertension and to relieve the clinical symptoms of benign prostatic hyperplasia (BPH).
Form: tablets
Active substance Dosage doxazosin mesylate 2.44 mg ATC: C02CA04
Manufacturer: Generis Farmaceutica, S.A.
-
The medicine is used in the treatment of essential hypertension and in the relief of clinical symptoms of benign prostatic hyperplasia (BPH).
Form: tablets
Active substance Dosage doxazosin mesylate 4.87 mg ATC: C02CA04
Manufacturer: Generis Farmaceutica, S.A.
-
The medicine is used to treat essential hypertension and to relieve the clinical symptoms of benign prostatic hyperplasia.
Form: tablets
Active substance Dosage doxazosin mesylate 1.213 mg ATC: C02CA04
Manufacturer: Pfizer Manufacturing Deutschland GmbH
-
The medicine is used to treat essential hypertension and to relieve the clinical symptoms of benign prostatic hyperplasia (BPH).
Form: tablets
Active substance Dosage doxazosin mesylate 4 mg ATC: C02CA04
Manufacturer: Pfizer Manufacturing Deutschland GmbH
-
It is used in the treatment of essential hypertension and to relieve the clinical symptoms of benign prostatic hyperplasia.
Form: tablets, modified release
Active substance Dosage doxazosin mesylate 5.093 mg ATC: C02CA04
Manufacturer: Klocke Verpackungs-Service GmbH, Pfizer Manufacturing Deutschland GmbH
-
The medicine is used in the treatment of essential hypertension and in the relief of clinical symptoms of benign prostatic hyperplasia (BPH).
Form: tablets, modified release
Active substance Dosage doxazosin mesylate 8 mg ATC: C02CA04
Manufacturer: Klocke Verpackungs-Service GmbH, Pfizer Manufacturing Deutschland GmbH
-
The medicine is used to treat essential hypertension and to relieve the symptoms of benign prostatic hyperplasia.
Form: tablets
Active substance Dosage doxazosin mesylate 1 mg ATC: C02CA04
Manufacturer: ICN Polfa Rzeszów S.A.
-
It is used in the treatment of essential hypertension and in the relief of clinical symptoms of benign prostatic hyperplasia.
Form: tablets
Active substance Dosage doxazosin mesylate 2 mg ATC: C02CA04
Manufacturer: ICN Polfa Rzeszów S.A.
-
The medicine is used to treat essential hypertension and to relieve the clinical symptoms of benign prostatic hyperplasia (BPH).
Form: tablets
Active substance Dosage doxazosin mesylate 4 mg ATC: C02CA04
Manufacturer: ICN Polfa Rzeszów S.A.
-
Doxar is used to treat essential hypertension and to relieve symptoms associated with benign prostatic hyperplasia (BPH).
Form: tablets
Active substance Dosage doxazosin mesylate 1.21 mg ATC: C02CA04
Manufacturer: Teva Operations Poland Sp. z o.o.
-
The medicine is used for the treatment of essential hypertension and for the relief of clinical symptoms of benign prostatic hyperplasia (BPH).
Form: tablets
Active substance Dosage doxazosin mesylate 2 mg ATC: C02CA04
Manufacturer: Teva Operations Poland Sp. z o.o.
-
Doxar is used to treat essential hypertension and to relieve the clinical symptoms of benign prostatic hyperplasia (BPH).
Form: tablets
Active substance Dosage doxazosin mesylate 4.85 mg ATC: C02CA04
Manufacturer: Teva Operations Poland Sp. z o.o.
-
The medicine is used to treat high blood pressure in women and men and to relieve symptoms associated with an enlarged prostate in men (e.g., frequent or weak urination).
Form: tablets, prolonged release
Active substance Dosage doxazosin mesylate 4.85 mg ATC: C02CA04
Manufacturer: Actavis Group PTC ehf.
-
It is used in the treatment of arterial hypertension and to relieve the symptoms of an enlarged prostate.
Form: tablets
Active substance Dosage doxazosin mesylate 1.21 mg ATC: C02CA04
Manufacturer: Adamed Pharma S.A. APL Swift Services (Malta) Ltd.
-
The medicine is used to treat mild enlargement of the prostate gland that causes difficulty in urination, and to treat high blood pressure (when other medicines have not been effective).
Form: tablets
Active substance Dosage doxazosin mesylate 2.43 mg ATC: C02CA04
Manufacturer: Polpharma Pharmaceutical Works S.A.
-
The medicine is used to treat arterial hypertension and to relieve symptoms caused by benign prostatic hyperplasia.
Form: tablets, modified release
Active substance Dosage doxazosin mesylate 4.85 mg ATC: C02CA04
Manufacturer: Krka, d.d., Novo mesto
-
Zoxon is used to treat essential hypertension and to relieve the clinical symptoms of benign prostatic hyperplasia (BPH).
Form: tablets
Active substance Dosage doxazosin mesylate 1.213 mg ATC: C02CA04
Manufacturer: Zentiva, joint-stock company
-
The medicine is used in the treatment of essential hypertension and in the relief of clinical symptoms of benign prostatic hyperplasia (BPH).
Form: tablets
Active substance Dosage doxazosin mesylate 2.425 mg ATC: C02CA04
Manufacturer: Zentiva, joint-stock company
-
Zoxon is used to treat essential hypertension and to relieve symptoms associated with benign prostatic hyperplasia (BPH).
Form: tablets
Active substance Dosage doxazosin mesylate 4 mg ATC: C02CA04
Manufacturer: Zentiva, joint-stock company